Four clinically relevant molecular subtypes of breast cancer, luminal A, luminal B, Her2+ type, and basal type, are different in terms of their morbidity, survival rate, prognosis, and tumor biological characteristics. This evidence concerns the gene ERBB2 and breast cancer.